Candriam S.C.A. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 104 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$7,930,000
-49.2%
393,390
-5.9%
0.05%
-49.5%
Q2 2021$15,609,000
-47.6%
418,245
-70.3%
0.11%
-56.9%
Q1 2021$29,816,000
-3.9%
1,408,9930.0%0.25%
+0.8%
Q4 2020$31,041,000
+42.7%
1,408,993
+16.5%
0.25%
+20.6%
Q3 2020$21,753,000
-36.2%
1,209,206
-10.0%
0.20%
-43.3%
Q2 2020$34,121,000
+80.2%
1,343,269
+52.7%
0.36%
+71.4%
Q1 2020$18,940,000
-2.2%
879,5000.0%0.21%
+1.0%
Q4 2019$19,375,000
+87.5%
879,500
+22.2%
0.21%
+51.8%
Q3 2019$10,332,000
+4.8%
719,500
+50.0%
0.14%
+11.4%
Q2 2019$9,860,000
+50.4%
479,800
+7.2%
0.12%
+46.4%
Q1 2019$6,556,000
+37.0%
447,5000.0%0.08%
+13.5%
Q4 2018$4,784,000
+7.6%
447,500
+53.5%
0.07%
+25.4%
Q3 2018$4,448,000
+203.6%
291,500
+177.6%
0.06%
+96.7%
Q2 2015$1,465,000
-58.0%
105,000
-27.6%
0.03%
-57.1%
Q1 2015$3,485,000
+92.3%
145,000
+31.8%
0.07%
+84.2%
Q4 2014$1,812,000110,0000.04%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$103,638,00010.86%
Aquilo Capital Management, LLC 1,454,686$36,949,0007.45%
RTW INVESTMENTS, LP 7,152,918$181,684,0005.11%
EcoR1 Capital, LLC 2,721,993$69,139,0005.11%
BRIDGER MANAGEMENT, LLC 1,473,568$37,429,0003.47%
DAFNA Capital Management LLC 454,236$11,538,0003.33%
Parkman Healthcare Partners LLC 300,805$7,640,0002.15%
ACUTA CAPITAL PARTNERS, LLC 170,000$4,318,0001.25%
Integral Health Asset Management, LLC 110,000$2,794,0000.84%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,013,087$25,732,0000.63%
View complete list of DICERNA PHARMACEUTICALS INC shareholders